BIOLOGIC USE IS ASSOCIATED WITH A MAJOR REDUCTION IN VENOUS THROMBOEMBOLIC EVENTS COMPARED WITH STEROID USE IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE

(1) University of Michigan

(2) ABBOTT LABORATORIES



This item was part of the Safety of anti-TNFs and immunomodulators in IBD session at UEG Week Stockholm 2011

This item can be cited as: Gut 2011; 60 (Suppl 3) A34

Categorisation:

  • Format
    • Abstract
  • Language
    • English
  • Year
    • 2011